Secondary myeloid/natural killer cell acute leukemia following T-cell lymphoma

Citation
Jj. Lee et al., Secondary myeloid/natural killer cell acute leukemia following T-cell lymphoma, LEUK LYMPH, 41(3-4), 2001, pp. 457-460
Citations number
15
Categorie Soggetti
Hematology,"Onconogenesis & Cancer Research
Journal title
LEUKEMIA & LYMPHOMA
ISSN journal
10428194 → ACNP
Volume
41
Issue
3-4
Year of publication
2001
Pages
457 - 460
Database
ISI
SICI code
1042-8194(200104)41:3-4<457:SMKCAL>2.0.ZU;2-B
Abstract
A 56-year-old woman was treated with combination chemotherapy and radiation therapy for peripheral T-cell lymphoma. Following complete remission for a period of 6 months, she returned again with marked leukocytosis. Leukemic cells were characterized by scanty cytoplasm with fine azurophilic granules , and were highly positive for myeloperoxidase and sudan black-B. Immunophe notypic analysis revealed that blast cells were positive for myeloid antige ns (CD13, CD33), and natural killer (NK) cell antigen (CD56), but negative for T-cell antigens (CD2, CD5, CD7), B-cell antigens (CD19, CD20), CD34, an d HLA-DR. The case was diagnosed as secondary myeloid/NK cell acute leukemi a following non-Hodgkin's lymphoma, Despite aggressive chemotherapy against leukemia, she died of multiorgan failure 7 months following onset of Leuke mia. We present. to the best of our knowledge. the first published report o f what seems to be a secondary myeloid/NK cell acute leukemia following T-c ell lymphoma.